Related references
Note: Only part of the references are listed.Exploring the Clinical Utility of Pancreatic Cancer Circulating Tumor Cells
Dannel Yeo et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Tumor-Stroma Interaction in PDAC as a New Approach for Liquid Biopsy and its Potential Clinical Implications
Julian Goetze et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2022)
Clinical Applications of Cancer-Associated Cells Present in the Blood of Cancer Patients
Cha-Mei Tang et al.
BIOMEDICINES (2022)
Circulating tumor cell-blood cell crosstalk: Biology and clinical relevance
Thais Pereira-Veiga et al.
CELL REPORTS (2022)
Characterization of RARRES1 Expression on Circulating Tumor Cells as Unfavorable Prognostic Marker in Resected Pancreatic Ductal Adenocarcinoma Patients
Christine Nitschke et al.
CANCERS (2022)
Proficiency Testing to Assess Technical Performance for CTC-Processing and Detection Methods in CANCER-ID
Rui P. L. Neves et al.
CLINICAL CHEMISTRY (2021)
CD74 and CD44 Expression on CTCs in Cancer Patients with Brain Metastasis
Desiree Loreth et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Pre-Analytical and Analytical Variables of Label-Independent Enrichment and Automated Detection of Circulating Tumor Cells in Cancer Patients
Claudia Koch et al.
CANCERS (2020)
Circulating Giant Tumor-Macrophage Fusion Cells Are Independent Prognosticators in Patients With NSCLC
Yariswamy Manjunath et al.
JOURNAL OF THORACIC ONCOLOGY (2020)
Liquid biopsy and minimal residual disease - latest advances and implications for cure
Klaus Pantel et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2019)
High Clinical Value of Liquid Biopsy to Detect Circulating Tumor Cells and Tumor Exosomes in Pancreatic Ductal Adenocarcinoma Patients Eligible for Up-Front Surgery
Etienne Buscail et al.
CANCERS (2019)
Circulating Tumor Cells in Pancreatic Cancer: Current Perspectives
Verena Martini et al.
CANCERS (2019)
Improved Risk Stratification by Circulating Tumor Cell Counts in Pancreatic Cancer
Katharina E. Effenberger et al.
CLINICAL CANCER RESEARCH (2018)
Cell fusion potentiates tumor heterogeneity and reveals circulating hybrid cells that correlate with stage and survival
Charles E. Gast et al.
SCIENCE ADVANCES (2018)
Tumacrophage: macrophages transformed into tumor stem-like cells by virulent genetic material from tumor cells
Yizhuang Zhang et al.
ONCOTARGET (2017)
Stealth dissemination of macrophage-tumor cell fusions cultured from blood of patients with pancreatic ductal adenocarcinoma
Gary A. Clawson et al.
PLOS ONE (2017)
Prognostic values of cancer associated macrophage-like cells (CAML) enumeration in metastatic breast cancer
Zhaomei Mu et al.
BREAST CANCER RESEARCH AND TREATMENT (2017)
Circulating Cancer-Associated Macrophage-Like Cells Differentiate Malignant Breast Cancer and Benign Breast Conditions
Daniel L. Adams et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2016)
Circulating tumor cell technologies
Meghaan M. Ferreira et al.
MOLECULAR ONCOLOGY (2016)
Macrophage-Tumor Cell Fusions from Peripheral Blood of Melanoma Patients
Gary A. Clawson et al.
PLOS ONE (2015)
Prognostic Role of Circulating Tumor Cells in Patients with Pancreatic Cancer: a Meta-analysis
Xue-Lei Ma et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2014)
Circulating giant macrophages as a potential biomarker of solid tumors
Daniel L. Adams et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Heterogeneous atypical cell populations are present in blood of metastatic breast cancer patients
Maryam B. Lustberg et al.
BREAST CANCER RESEARCH (2014)